Quality of life and survival: The role of multidimensional symptom assessment

Cancer

Volumn 83, Issue 1, 1998, Pages 173-179

  Chang, Victor T ^a,b,e   Thaler, Howard T ^c   Polyak, Tatyana A ^c   Kornblith, Alice B ^c   Lepore, Jean M ^c   Portenoy, Russell K ^c,d  

^a Section of Hematology and Oncology   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d BETH ISRAEL MEDICAL CENTER   (United States)

^e Section Hematology/Oncology (111)   (United States)

Author keywords

Distress; Neoplasm; Quality of life; Survival; Symptoms

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER SURVIVAL; COLON CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MULTIVARIATE ANALYSIS; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; SCORING SYSTEM; SYMPTOMATOLOGY;

ADULT; AGED; AGED, 80 AND OVER; HUMANS; MIDDLE AGED; NEOPLASMS; QUALITY OF LIFE; SURVIVAL RATE;

EID: 0032127372     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19980701)83:1<173::AID-CNCR23>3.0.CO;2-T     Document Type: Article

References (41)

1. Parkes CM. Accuracy of predictions of survival in later stages of cancer. Br Med J 1972;2:29-31.
2. Miller RJ. Predicting survival in the advanced cancer patient. Henry Ford Hosp Med J 1991;39:81-4.
3. Yates JW, Chalmer B, McKegney FP. Evaluation of patients with advanced cancer using the Karnofsky performance status. Cancer 1980;45:2220-4.
4. Lassauniere JM, Vinant P. Prognostic factors, survival, and advanced cancer. J Palliat Care 1992;8:52-4.
5. Hardy JR, Turner R, Saunders M, A'Hern R. Prediction of survival in a hospital-based continuing care unit. Eur J Cancer 1994;30A:284-8.
6. Heyse-Moore LH, Johnson-Bell VE. Can doctors accurately predict the life expectancy of patients with terminal cancer? Palliat Med 1987;1:165-6.
7. Stanley KE. Prognostic factors for survival in patients with inoperable lung cancer. J Natl Cancer Inst 1980;65:25-32.
8. Reuben DB, Mor V, Hiris J. Clinical symptoms and length of survival in patients with terminal cancer. Arch Intern Med 1988;148:1586-91.
9. Maltoni M, Pirovano M, Scarpi E, Marinari M, Indelli M, Arnoldi E, et al. Prediction of survival of patients terminally ill with cancer. Results of an Italian prospective multicentric study. Cancer 1995;75:2613-22.
10. Rana A, Chisholm GD, Rashwan HM, Salim A, Merrick MV, Elton RA. Symptomatology of metastatic prostate cancer: prognostic significance. Br J Urol 1994;73:683-6.
11. Graf W, Glimelius B, Pahlman L, Bergstrom R. Determinants of prognosis in advanced colorectal cancer. Eur J Cancer 1991;27:1119-23.
12. Bruera E, Miller MJ, Kuehn N, MacEachern T, Hanson J. Estimate of survival of patients admitted to a palliative care unit: a prospective study. J Pain Symptom Manage 1992;7: 82-6.
13. Earlam S, Glover C, Fordy C, Burke D, Allen-Mersh TG. Relation between tumor size, quality of life, and survival in patients with colorectal liver metastases. J Clin Oncol 1996; 14:171-5.
14. Ganz PA, Lee JJ, Siau J. Quality of life assessment. An independent prognostic variable for survival in lung cancer. Cancer 1991;67:3131-5.
15. Ruckdeschel JC, Piantadosi S, Lung Cancer Study Group. Quality-of-life assessment in lung surgery for bronchogenic carcinoma. J Theor Surg 1991;6:201-5.
16. Kaasa S, Mastekaasa A, Lund E. Prognostic factors for patients with inoperable non-small cell lung cancer, limited disease. Radiother Oncol 1989;15:235-42.
17. Coates A, Gebski V, Signorini D, Murray P, McNeil D, Byrne M, et al. Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer. J Clin Oncol 1992;10:1833-8.
18. Coates A, Thomson D, McLeod GRM, Hersey P, Gill PG, Olver IN, et al. Prognostic value of quality of life scores in a trial of chemotherapy with or without interferon in patients with metastatic malignant melanoma. Eur J Cancer 1993; 29A:1731-4.
19. Portenoy RK, Thaler HT, Kornblith AB, Lepore JM, Friedlander-Klar H, Kiyasu E, et al. The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer 1994;30A:1226-36.
20. Brook RH, Ware JE Jr., Davies-Avery A, Stewart AL, Donald CA, Rogers WH, et al. Conceptualization and measurement of health for adults. The Health Insurance Study: overview, Vol. VIII. Santa Monica, CA: RAND, October, 1979.
21. Ware JE Jr., Johnston SA, Davies-Avery A, Brook RH. Conceptualization and measurement of health for adults. The Health Insurance Study: mental health, vol. III. Santa Monica, CA: RAND, December, 1979.
22. McCorkle R, Yound K. Development of a symptom distress scale. Cancer Nurs 1978;1:373-8.
23. Schipper H, Clinch J, McMurray A, Levitt M. Measuring the quality of life of cancer patients: the Functional Living Index - cancer. Development and validation. J Clin Oncol 1984;2:472-83.
24. Portenoy RK, Thaler HT, Kornblith AB, Lepore JM, Friedlander-Klar H, Coyle N, et al. Symptom prevalence, characteristics, and distress in a cancer population. Qual Life Res 1994;3:183-9.
25. Kent JT, O'Quigley J. Measures of dependence for censored survival data. Biometrika 1988;75:525-34.
26. Clinch JJ. The Functional Living Index - cancer: ten years later. In: Spilker B, editor. Quality of life and pharmacoeconomics in clinical trials. Philadelphia: Lippincott-Raven Publishers, 1996:215-25.
27. Chang VT, Thaler HT, Polyak T, Kornblith AB, Lepore JM, Friedlander-Klar H, et al. Quality of life and survival: the role of symptom distress [abstract 1597]. Proc Am Soc Clin Oncol 1994;13:460.
28. Loprinzi CL, Laurie JA, Wieand HS, Krook JE, Novotny PJ, Kugler JW, et al. Prospective evaluation of prognostic variables from patient-completed questionnaires. J Clin Oncol 1994;12:601-7.
29. Ventafridda F, Ripamonti C, Tamburini M, Cassileth RB, DeConno F. Unendurable symptoms as prognostic indicators of impending death in terminal cancer patients. Eur J Cancer 1990;26:1000-1.
30. Degner LF, Sloan JA. Symptom distress in newly diagnosed ambulatory cancer patients and as a predictor of survival in lung cancer. J Pain Symptom Manage 1995;10: 423-31.
31. Seidman AD, Portenoy RK, Yao T-J, Lepore J, Mont EK, Kortmansky, et al. Quality of life in Phase II trials: a study of methodology and predictive value in patients with advanced breast cancer treated with paclitaxel plus granulocyte colony-stimulating factor. J Natl Cancer Inst 1995; 87:1316-22.
32. Slevin ML, Plant H, Lynch D, Drinkwater J, Gregory WM. Who should measure quality of life, the doctor or the patient? Br J Cancer 1988;57:109-12.
33. Mor V. Cancer patients quality of life over the disease course: lessons from the real world. J Chron Dis 1987;40:535-44.
34. Chang VT, Hwang SS, Kasimis BS. Symptom and quality of life survey of oncology patients at a VA medical center [abstract 1726]. Proc ASCO 1995;14:525.
35. Cassileth BR, Lusk EJ, Miller DS, Brown LL, Miller C. Psychosocial correlates of survival in advanced malignant disease? New Engl J Med 1985;312:1551-5.
36. Silberfarb PM, Anderson KM, Rundle AC, Holland JCB, Cooper MR, McIntyre OR. Mood and clinical status in patients with multiple myeloma. J Clin Oncol 1991;9:2219-24.
37. Tross S, Herndon J II, Korzun A, Kornblith AB, Cella DF, Holland JF, et al. Psychological symptoms and disease-free and overall survival in women with Stage II breast cancer. J Natl Cancer Inst 1996;88:661-7.
38. Spiegel D, Bloom JR, Kraemer HC, Gottheil E. The effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet 1989;2:888-91.
39. Cleeland CS, Gonin R, Hatfield AK, Edmondson JH, Blum RH, Stewart JA, et al. Pain and its treatment in outpatients with metastatic cancer. N Engl J Med 1994;330:592-6.
40. Piccirillo JF, Feinstein AR. Clinical symptoms and comorbidity: significance for the prognostic classification of cancer. Cancer 1996;77:834-42.
41. Chang VT, Hwang SS, Corpion C, Feuerman M. Validation of the Memorial Symptom Assessment Scale Short Form (MSAS-SF) [abstract 165]. Proc Am Soc Clin Oncol 1997;16: 47a.